(MENAFN- PR Newswire)
DUBLIN, Aug. 12, 2022 /PRNewswire/ -- The 'Global Artificial Intelligence (AI) in Drug Discovery Market (2022-2027) by Offering, Drug Type, Technology, Applications, End-Users, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis' report has been added to ResearchAndMarkets.com's offering.
The Global Artificial Intelligence (AI) in Drug Discovery Market is estimated to be USD 792.45 Mn in 2022 and is expected to reach USD 2337.25 Mn by 2027, growing at a CAGR of 24.15%.Market dynamics are forces that impact the prices and behaviors of the Global Artificial Intelligence (AI) in Drug Discovery Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors.
There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.
Company Profiles
The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Aria Pharmaceuticals, Cloud Pharmaceuticals, Inc., Cyclica Inc., Google LLC, IBM Corp., Microsoft Corp., Owkin, Inc., Verge Genomics Inc., XtalPi Inc., etc. Countries Studied
- America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
- Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
- Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
- Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc. Ansoff Analysis
The report presents a detailed Ansoff matrix analysis for the Global Artificial Intelligence (AI) in Drug Discovery Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach. The analyst analyses the Global Artificial Intelligence (AI) in Drug Discovery Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth. Why buy this report?
- The report offers a comprehensive evaluation of the Global Artificial Intelligence (AI) in Drug Discovery Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
- The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.
Key Topics Covered: 1 Report Description 2 Research Methodology 3 Executive Summary 3.1 Introduction3.2 Market Size, Segmentations, and Outlook 4 Market Dynamics 4.1 Drivers4.1.1 Growing Need to Control Drug Discovery 4.1.2 Reduce Time Involved in Drug Development4.1.3 Patent Expiry of Several Drugs4.1.4 Growing Number of Cross-Industry Collaborations and Partnerships4.2 Restraints4.2.1 Shortage of AI Workforce and Ambiguous Regulatory Guidelines for Medical Software4.2.2 High Initial Cost4.3 Opportunities4.3.1 AI Cloud to Create a Streamlined and Automated Approach to Drug Discovery4.3.2 Rising R&D Investment4.4 Challenges4.4.1 Limited Availability of Data Sets 5 Market Analysis 5.1 Regulatory Scenario5.2 Porter's Five Forces Analysis5.3 Impact of COVID-195.4 Ansoff Matrix Analysis 6 Global Artificial Intelligence (AI) in Drug Discovery Market, By Offering 6.1 Introduction6.2 Software6.3 Services 7 Global Artificial Intelligence (AI) in Drug Discovery Market, By Drug Type 7.1 Introduction7.2 Small Molecules 7.3 Large Molecules 8 Global Artificial Intelligence (AI) in Drug Discovery Market, By Technology 8.1 Introduction8.2 Machine Learning8.3 Deep Learning8.4 Supervised Learning8.5 Reinforcement Learning8.6 Unsupervised Learning8.7 Other Technologies 9 Global Artificial Intelligence (AI) in Drug Discovery Market, By Applications 9.1 Introduction9.2 Oncology9.3 Infectious Diseases9.4 Neurological Disorders9.5 Metabolic Diseases9.6 Cardiovascular Diseases9.7 Others 10 Global Artificial Intelligence (AI) in Drug Discovery Market, By End-Users 10.1 Introduction10.2 Pharmaceutical & Biotechnology Companies10.3 Contract Research Organizations10.4 Research Centers and Academic & Government Institutes 11 Americas' Artificial Intelligence (AI) in Drug Discovery Market 11.1 Introduction11.2 Argentina11.3 Brazil11.4 Canada11.5 Chile11.6 Colombia11.7 Mexico11.8 Peru11.9 United States11.10 Rest of Americas 12 Europe's Artificial Intelligence (AI) in Drug Discovery Market 12.1 Introduction12.2 Austria12.3 Belgium12.4 Denmark12.5 Finland12.6 France12.7 Germany12.8 Italy12.9 Netherlands12.10 Norway12.11 Poland12.12 Russia12.13 Spain12.14 Sweden12.15 Switzerland12.16 United Kingdom12.17 Rest of Europe 13 Middle East and Africa's Artificial Intelligence (AI) in Drug Discovery Market 13.1 Introduction13.2 Egypt13.3 Israel13.4 Qatar13.5 Saudi Arabia13.6 South Africa13.7 United Arab Emirates13.8 Rest of MEA 14 APAC's Artificial Intelligence (AI) in Drug Discovery Market 14.1 Introduction14.2 Australia14.3 Bangladesh14.4 China14.5 India14.6 Indonesia14.7 Japan14.8 Malaysia14.9 Philippines14.10 Singapore14.11 South Korea14.12 Sri Lanka14.13 Thailand14.14 Taiwan14.15 Rest of Asia-Pacific 15 Competitive Landscape 15.1 Competitive Quadrant15.2 Market Share Analysis15.3 Strategic Initiatives15.3.1 M&A and Investments15.3.2 Partnerships and Collaborations15.3.3 Product Developments and Improvements 16 Company Profiles 16.1 Aria Pharmaceuticals16.2 Atomwise, Inc.16.3 BenchSci16.4 BenevolentAI Ltd.16.5 Berg LLC16.6 BioSymetrics Inc.16.7 BIOAGE16.8 Cloud Pharmaceuticals, Inc.16.9 Cyclica Inc.16.10 Deep Genomics Inc.16.11 EXSCIENTIA16.12 Envisagenics, Inc.16.13 Google LLC16.14 Insilico Medicine16.15 IBM Corp.16.16 Microsoft Corp.16.17 Novartis International Ag16.18 NuMedii, Inc.16.19 NVIDIA Corp.16.20 Owkin, Inc.16.21 Standigm Inc.16.22 Schrodinger, Inc.16.23 Valo Health, Inc.16.24 Twoxar, Inc. (Aria Pharmaceuticals)16.25 Verge Genomics Inc.16.26 XtalPi Inc. 17 Appendix For more information about this report visit
Media Contact:
Research and MarketsLaura Wood, Senior Manager[email protected]
For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716
Logo:
SOURCE Research and Markets
MENAFN12082022003732001241ID1104688218
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.